ursolic acid has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bagle, S; Dighe, V; Kaikini, A; Muke, S; Peshattiwar, V; Sathaye, S | 1 |
| Birla, H; Dilnashin, H; Keswani, C; Rai, SN; Rathore, AS; Singh, R; Singh, RK; Singh, SP; Singh, SS; Zahra, W | 2 |
3 other study(ies) available for ursolic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson's disease- emphasizing the role of mitochondrial biogenesis.
Topics: Animals; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Glutathione; Male; Mitochondria; Organelle Biogenesis; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Triterpenes; Ursolic Acid | 2020 |
Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model.
Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Disease Models, Animal; Dopaminergic Neurons; Male; Mice; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Rotenone; Triterpenes; Ursolic Acid | 2020 |
Anti-inflammatory Activity of Ursolic Acid in MPTP-Induced Parkinsonian Mouse Model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antiparkinson Agents; Brain; Catalase; Fluorescent Antibody Technique; Glutathione; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Mice; Nitrites; Parkinsonian Disorders; Psychomotor Performance; Real-Time Polymerase Chain Reaction; Rotarod Performance Test; Triterpenes; Ursolic Acid | 2019 |